These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 9595780

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Blood pressure and serum potassium levels in hypertensive patients receiving or not receiving antihypertensive treatment.
    Pikilidou MI, Lasaridis AN, Sarafidis PA, Tziolas IM, Zebekakis PE, Dombros NV, Giannoulis E.
    Clin Exp Hypertens; 2007 Nov; 29(8):563-73. PubMed ID: 18058481
    [Abstract] [Full Text] [Related]

  • 23. The relationship between microalbuminuria in first generation diabetic and non-diabetic subjects and microalbuminuria and hypertension in the second generation (a population based study).
    Vestbo E, Damsgaard EG, Mogensen CE.
    Nephrol Dial Transplant; 1997 Nov; 12 Suppl 2():32-6. PubMed ID: 9269697
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Microalbuminuria in essential arterial hypertension].
    Redón J, Pascual JM, Miralles A, Sanz C, Gutiérrez M, Ros MJ, Baldó E, Michavila J, Sánchez C, Alegre B.
    Med Clin (Barc); 1991 Apr 13; 96(14):525-9. PubMed ID: 2051803
    [Abstract] [Full Text] [Related]

  • 26. Urinary albumin excretion in lean, overweight and obese glucose tolerant individuals: its relationship with dyslipidaemia, hyperinsulinaemia and blood pressure.
    Hoffmann IS, Jimenez E, Cubeddu LX.
    J Hum Hypertens; 2001 Jun 13; 15(6):407-12. PubMed ID: 11439316
    [Abstract] [Full Text] [Related]

  • 27. [Quality of life in patients with essential arterial hypertension. Part II: The effect of clinical factors].
    Klocek M, Kawecka-Jaszcz K.
    Przegl Lek; 2003 Jun 13; 60(2):101-6. PubMed ID: 12939856
    [Abstract] [Full Text] [Related]

  • 28. The effect of rosiglitazone on urine albumin excretion in patients with type 2 diabetes mellitus and hypertension.
    Sarafidis PA, Lasaridis AN, Nilsson PM, Hitoglou-Makedou AD, Pagkalos EM, Yovos JG, Pliakos CI, Tourkantonis AA.
    Am J Hypertens; 2005 Feb 13; 18(2 Pt 1):227-34. PubMed ID: 15752951
    [Abstract] [Full Text] [Related]

  • 29. A comparison of body mass index and waist-to-hip ratio as indicators of hypertension risk in an urban Argentine population: a hospital-based study.
    Feldstein CA, Akopian M, Olivieri AO, Kramer AP, Nasi M, Garrido D.
    Nutr Metab Cardiovasc Dis; 2005 Aug 13; 15(4):310-5. PubMed ID: 16054556
    [Abstract] [Full Text] [Related]

  • 30. Lowering the threshold for defining microalbuminuria: effects of a lifestyle-metformin intervention in obese "normoalbuminuric" non-diabetic subjects.
    Cubeddu LX, Alfieri AB, Hoffmann IS.
    Am J Hypertens; 2008 Jan 13; 21(1):105-10. PubMed ID: 18091752
    [Abstract] [Full Text] [Related]

  • 31. [Relationship in cardiovascular reactivity to mental stress and early involvement of target organs in non-treated mild arterial hypertension. Hospitalet Study].
    Armario P, Hernández del Rey R, Torres G, Martín-Baranera M, Cruz Almendros M, Pardell H.
    Med Clin (Barc); 1999 Oct 09; 113(11):401-6. PubMed ID: 10562950
    [Abstract] [Full Text] [Related]

  • 32. Clinical features, anthropometric characteristics, and racial influences on the 'white-coat effect' in a single-centre cohort of 1553 consecutive subjects undergoing routine ambulatory blood pressure monitoring.
    Gualdiero P, Niebauer J, Addison C, Clark SJ, Coats AJ.
    Blood Press Monit; 2000 Apr 09; 5(2):53-7. PubMed ID: 10828890
    [Abstract] [Full Text] [Related]

  • 33. The correlation of office blood pressure and 24-hour ambulatory measurements in hypertensive patients - comparison between non-pharmacological treatment and antihypertensive medication.
    Dzien A, Pfeiffer K, Dzien-Bischinger C, Hoppichler F, Lechleitner M.
    Eur J Med Res; 2000 Jun 20; 5(6):268-72. PubMed ID: 10882643
    [Abstract] [Full Text] [Related]

  • 34. Association between serum uric acid, metabolic syndrome and microalbuminuria in previously untreated essential hypertensive patients.
    Rodilla E, Pérez-Lahiguera F, Costa JA, González C, Miralles A, Moral D, Pascual JM.
    Med Clin (Barc); 2009 Jan 17; 132(1):1-6. PubMed ID: 19174057
    [Abstract] [Full Text] [Related]

  • 35. Cardiorenal risk prevalence in sickle cell hemoglobinopathy.
    Abo-Zenah H, Moharram M, El Nahas AM.
    Nephron Clin Pract; 2009 Jan 17; 112(2):c98-c106. PubMed ID: 19390209
    [Abstract] [Full Text] [Related]

  • 36. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M.
    Hypertens Res; 2007 Apr 17; 30(4):301-6. PubMed ID: 17541208
    [Abstract] [Full Text] [Related]

  • 37. The bedtime administration of doxazosin controls morning hypertension and albuminuria in patients with type-2 diabetes: evaluation using home-based blood pressure measurements.
    Kamoi K, Ikarashi T.
    Clin Exp Hypertens; 2005 May 17; 27(4):369-76. PubMed ID: 15921073
    [Abstract] [Full Text] [Related]

  • 38. Microalbuminuria and uric acid in healthy subjects.
    Bellomo G, Berardi P, Saronio P, Verdura C, Esposito A, Laureti A, Venanzi S, Timio F, Timio M.
    J Nephrol; 2006 May 17; 19(4):458-64. PubMed ID: 17048203
    [Abstract] [Full Text] [Related]

  • 39. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
    Estacio RO, Jeffers BW, Gifford N, Schrier RW.
    Diabetes Care; 2000 Apr 17; 23 Suppl 2():B54-64. PubMed ID: 10860192
    [Abstract] [Full Text] [Related]

  • 40. Blood pressure at diagnosis of type 2 diabetes correlates with plasma insulin concentration but not during the next 5 years.
    Lowenthal LM, Pim B, Hillson RM, Dhar H, Hockaday TD.
    Diabetes Res; 1985 Mar 17; 2(2):65-9. PubMed ID: 3899461
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.